id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-P-0471-0010,FDA,FDA-2009-P-0471,"FDA/CDER Response to Mark Antell, et al - Petition Partial Approval and Denial",Other,PPAD-Petition Partial Approval and Denial,2010-04-30T04:00:00Z,2010,4,2010-04-30T04:00:00Z,,2013-07-27T23:17:05Z,,0,0,0900006480ae178e
FDA-2009-P-0471-0009,FDA,FDA-2009-P-0471,"FDA/CDER Interim Response to Mark Antell, et al - Letter",Other,LET-Letter,2010-04-09T04:00:00Z,2010,4,2010-04-09T04:00:00Z,,2013-07-27T23:15:20Z,,0,0,0900006480ad44ba
FDA-2009-P-0471-0008,FDA,FDA-2009-P-0471,"Mark Antell, et al - Supplement",Other,SUP-Supplement,2010-02-01T05:00:00Z,2010,2,2010-02-01T05:00:00Z,,2013-08-11T04:37:00Z,,0,0,0900006480a6a34e
FDA-2009-P-0471-0007,FDA,FDA-2009-P-0471,"Mark Antell, et al - Supplement",Other,SUP-Supplement,2009-12-11T05:00:00Z,2009,12,2009-12-11T05:00:00Z,,2013-07-27T23:00:42Z,,0,0,0900006480a5dd84
FDA-2009-P-0471-0006,FDA,FDA-2009-P-0471,"Acknowledgement Letter to Mark Antell, et al",Other,ACK-Acknowledgement Letter,2009-10-05T04:00:00Z,2009,10,2009-10-05T04:00:00Z,,2010-02-01T22:10:22Z,,0,0,0900006480a33577
FDA-2009-P-0471-0002,FDA,FDA-2009-P-0471,"Tab 1 - ""Treatment of Hepatitis C in Patients With Haemophilia - the Israeli National Hemophilia Center Experience"" - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-10-05T04:00:00Z,2009,10,,,2010-02-01T22:17:59Z,,0,0,0900006480a334e8
FDA-2009-P-0471-0003,FDA,FDA-2009-P-0471,"Tab 3 - ""HCV Treatment With Pegylated Interferon and Ribavirin in Patients With Haemophilia and HIV/HCV Co-Infection"" - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001",Supporting & Related Material,BKG-Background Material,2009-10-05T04:00:00Z,2009,10,,,2010-02-01T22:18:53Z,,0,0,0900006480a33573
FDA-2009-P-0471-0004,FDA,FDA-2009-P-0471,"Tab 4b - ""United Kingdom Liver Transplant Experience of HIV: Long Term Outcomes. D et al.,  - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-10-05T04:00:00Z,2009,10,,,2010-02-01T22:20:34Z,,0,0,0900006480a33575
FDA-2009-P-0471-0005,FDA,FDA-2009-P-0471,"Tab 5 - ""Hepatitis C Drug May Have the Length of Treatment, but Ribavirin Still Needed""  - [Mark Antell, et al - Citizen Petition ] re FDA-2009-P-0471-0001",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2009-10-05T04:00:00Z,2009,10,,,2010-02-01T22:21:09Z,,0,0,0900006480a33576
FDA-2009-P-0471-0001,FDA,FDA-2009-P-0471,"Mark Antell, et al - Citizen Petition",Other,CP-Citizen Petition,2009-10-05T04:00:00Z,2009,10,2009-10-05T04:00:00Z,,2013-08-11T04:35:48Z,,0,0,0900006480a334e7